AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Knowing when to pay off debt early is crucial. Evaluate your financial situation to make the best choices for your future.
25,016 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Cumberland, Fluid, and SwissBorg join Hashi ahead of Sui's July testnet launch, expanding Bitcoin-backed DeFi rails a...
Three legacy tech giants are pushing new strategies in 2026 as investors weigh durable enterprise moats against consu...
A new 530A account aims to boost child wealth, but uptake is tepid as July 4 launches draws near. Experts warn billio...
Meta Platforms rolls out a new AI compute offering for external customers, aiming to outpace cloud giants. The move t...
Inflation erodes retirement income as COLAs lag. This article explores the root causes, what lawmakers can change, an...
AI-powered analytics are accelerating real-time decisions in mortgage lending. This report explains how business inte...
Tom Zschach, who led SWIFT's digital asset strategy for six years, publicly dismissed XRP partnership rumors on July ...
Apple filed a federal lawsuit alleging trade secret theft by former employees at OpenAI, threatening hardware know-ho...
Goldman Sachs foresees a trillion-dollar space economy within the next two decades, underpinned by commercial growth ...
A rising domestic memory player is lining up a major public listing to challenge established DRAM leaders. Investors ...
NovaIndex introduces AI-powered index construction from a single prompt, with an uncapped 1% transfer match for new m...